Michael A. W. Eaton

North Carolina State University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index2.6kcitations59works4.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemical Synthesis and Analysis(11), DNA and Nucleic Acid Chemistry(10), Advanced biosensing and bioanalysis techniques(8), Monoclonal and Polyclonal Antibodies Research(8), Radiopharmaceutical Chemistry and Applications(7)

Publications59 total

Abstract 2482 Coniferyl alcohol rescues aberrant root development phenotypes of Arabidopsis lignin mutants
Journal of Biological Chemistry·2025Open Access
117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study
Immuno-Oncology Technology·2024· 9 citedOpen Access
Why healthcare open innovation is failing for nanomedicines
nano Online·2016
Nanomedicine: Past, present and future – A global perspective
Biochemical and Biophysical Research Communications·2015· 137 cited
Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry·2014· 9 cited
Why healthcare open innovation is failing for nanomedicines
European Journal of Nanomedicine·2013
Molecular analysis of intragenic recombination at the tryptophan synthetase locus in Neurospora crassa
Journal of Genetics·2013· 2 cited
Improving the translation in Europe of nanomedicines (a.k.a. drug delivery) from academia to industry
Journal of Controlled Release·2012· 16 cited
How do we develop nanopharmaceuticals under open innovation?
Nanomedicine Nanotechnology Biology and Medicine·2011· 28 cited
AUTHOR'S COPY How do we develop nanopharmaceuticals under open innovation?
2011
The Commercial Development of Antibodies as Drugs
Else Kröner-Fresenius Symposia·2011
PyCogent: a toolkit for making sense from sequence
Genome biology·2007· 205 citedOpen Access
CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors
Bioorganic & Medicinal Chemistry Letters·2002· 57 citedOpen Access
A New Self-Assembling System for Targeted Gene Delivery
Angewandte Chemie International Edition·2000· 22 cited
A New Self-Assembling System for Targeted Gene Delivery
Angewandte Chemie·2000· 17 cited
Synthesis of Cholesteryl Polyamine Carbamates:  p<i>K</i><sub>a</sub> Studies and Condensation of Calf Thymus DNA
Bioconjugate Chemistry·2000· 72 cited
The regiochemical distribution of positive charges along cholesterol polyamine carbamates plays significant roles in modulating DNA binding affinity and lipofection
FEBS Letters·1999· 69 cited
High-Yield Preparation of Oligomeric C-Type DNA Toroids and Their Characterization by Cryoelectron Microscopy
Journal of the American Chemical Society·1998· 249 cited
Synthesis of cholesterol-polyamine carbamates: pKa studies and condensation of calf thymus DNA
Chemical Communications·1998· 44 cited
The inhibition of antigen‐induced eosinophilia and bronchoconstriction by CDP840, a novel stereo‐selective inhibitor of phosphodiesterase type 4
British Journal of Pharmacology·1996· 95 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David Parker(9), Andrew T. Millican(9), T.A. Millican(7), T.P. Patel(7), N. H. Carey(5), Kenneth Millar(5), Alice Harrison(5), Catherine Catterall(4), Karl J. Jankowski(4), Nigel R. A. Beeley(4), Byron A. Boyce(4), Richard J. K. Taylor(4), Alison Phipps(4), D. W. Hutchinson(4), J.S. Emtage(3), Graham A. Mock(3), Stephen Neidle(3), John Mann(3), Chhanda Bose(3), Hilary Lewis(3)